Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 884Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13Cohance Lifesciences

02 3Deva Holding AS

03 5Devatis AG

04 17F. Hoffmann-La Roche

05 3Neuraxpharm

06 1Teva Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Dispersible Tablet

Dosage Strength : 50MG; 12.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Dispersible Tablet

Dosage Strength : 100MG; 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Immediate Release Capsule

Dosage Strength : 50MG; 12.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Immediate Release Capsule

Dosage Strength : 100MG; 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Immediate Release Capsule

Dosage Strength : 200 MG; 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Immediate Release Tablet

Dosage Strength : 50MG; 12.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Immediate Release Tablet

Dosage Strength : 100MG; 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Immediate Release Tablet

Dosage Strength : 200MG; 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Capsule

Dosage Strength : 100 MG; 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Capsule

Dosage Strength : 200 MG; 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

11

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Extended Release Granules

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

12

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Extended Release Granules

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

13

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Etilevodopa; Benserazide Hydrochloride

Brand Name :

Dosage Form : Extended Release Granules

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

14

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MG; 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

15

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG; 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

16

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name :

Dosage Form : Prolonged Release Hard Capsule

Dosage Strength : 100MG; 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

17

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopum; Benserazidum

Brand Name : Levodopa/Benserazid Devatis

Dosage Form : Tabl

Dosage Strength : 125mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

18

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopum; Benserazidum

Brand Name : Levodopa/Benserazid Devatis

Dosage Form : Tabl

Dosage Strength : 125mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

19

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopum; Benserazidum

Brand Name : Levodopa/Benserazid Devatis

Dosage Form : Tabl

Dosage Strength : 250mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

20

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopum; Benserazidum

Brand Name : Levodopa/Benserazid Devatis

Dosage Form : Tabl

Dosage Strength : 250mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

21

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopum; Benserazidum

Brand Name : Levodopa/Benserazid Devatis

Dosage Form : Tabl

Dosage Strength : 62.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

22

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name : Madopar

Dosage Form : Levodopa+Benserazide 200+50Mg 50 Combined Oral Use

Dosage Strength : 50 CPR 200 mg + 50 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

23

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name : Madopar

Dosage Form : Levodopa+Benserazide 100+25Mg 30 Joined' Oral Use

Dosage Strength : 30 cps 100 mg + 25 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

24

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name : Madopar

Dosage Form : Levodopa+Benserazide 100+25Mg 30 Joined' Oral Use

Dosage Strength : 30 cpr dispers 100 mg + 25 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

25

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name : Madopar

Dosage Form : Levodopa+Benserazide 100+25Mg 30 Joined' Oral Use Rp

Dosage Strength : 30 cps 100 mg + 25 mg prolonged release

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

26

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopum; Benserazidum

Brand Name : Madopar 125

Dosage Form : Kaps

Dosage Strength : 125mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

27

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benserazide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 50MG; 12.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

28

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benserazide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MG; 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

29

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benserazide

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG; 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

30

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name : Lodopa Benserazide

Dosage Form : Levodopa+Benserazide 200+50Mg 50 Combined Oral Use

Dosage Strength : 50 CPR 200 mg + 50 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank